GlassScriptPhysician profile
Michael Romeo
NPI 1740860964
$3,598.61
in general payments reported to CMS, 2019-2025
10 companies · $53.35 in 2025
The $53.35 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $180 · 2022: $1,292 · 2023: $986 · 2024: $1,087 · 2025: $53.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,126.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,917.90 | 2021-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $1,135.46 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $191.27 | 2022-2024 | Delstrigo, Pifeltro, Dificid |
| Janssen Biotech, INC. | $159.24 | 2022-2023 | Symtuza |
| Napo Pharmaceuticals INC | $76.44 | 2022-2023 | Mytesi |
| Theratechnologies INC. | $40.16 | 2024 | Trogarzo, Egrifta |
| Hologic Sales and Service, LLC | $26.06 | 2024 | Thinprep 2000 Processor, Aptima |
| Idorsia Pharmaceuticals US INC | $20.14 | 2022 | |
| Janssen Scientific Affairs, LLC | $16.47 | 2023 | Symtuza |
| Abbvie INC. | $15.47 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Romeo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.